Atlas Trials

Gastro-esophageal Junction Cancer

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastro-esophageal Junction Cancer

RecordFirmDate
Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer (NCT05053295)Gangnam Severance Hospital2021-07-02
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma (NCT03488667)University of Kansas Medical Center2018-06-27
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) (NCT03448835)The Netherlands Cancer Institute2018-03-07
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer (NCT02359968)Centre Oscar Lambret2015-02-26
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer (NCT01084330)Novartis Pharmaceuticals2010-04-01
Quality of Life With Esophageal Stent Trial (NCT01044511)Michael Bau Mortensen2010-01-01
Chemoradiation and Panitumumab for Esophageal Cancer (NCT01077999)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2010-01-01
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation (NCT00716157)Thomas Jefferson University2004-10-01
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00215514)Dana-Farber Cancer Institute2000-09-01

Track Gastro-esophageal Junction Cancer automatically

Every clearance here is in the API, with alerts when new ones post.